BUSINESS● LOW5d ago · Oct 9, 2026, 8:43 AM
Retension Pharmaceuticals prices upsized IPO at $12 per share
Seeking Alpha Tech · global
Retension Pharmaceuticals has priced its upsized initial public offering (IPO) at $12 per share. This signifies a standard corporate financing event in the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoBritish American Tobacco extends 5-day winning streak; RSI flags riskSeeking Alpha TechBUSINESS27m agoBetter Home & Finance stock dips as Q3 revenue is estimated below consensusSeeking Alpha Tech